Mednet Logo
HomeQuestion

What is your approach to the use of Paxlovid for patients with risk factors for severe Covid-19 infection but who have received SARS-CoV-2 vaccines in light of the EPIC-SR trial findings?

1
3 Answers
Mednet Member
Mednet Member
Infectious Disease · Ut Physicians Infectious Diseases Texas Medical Center

Although EPIC-SR Trial may not have shown a significant benefit of paxlovid in standard-risk patients regardless of vaccination status, EPIC HR and real-world evidence have shown benefits in high-risk populations. Shared decision-making with the patient is always the best policy.

Disclosure: I have r...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Infectious Disease · Cooperman Barnabas Medical Center

Hopefully, the question is moot. Two days ago, I asked my team when the last time we had a patient who even tested COVID+. I couldn't remember any. We may have had 1 patient, who tested COVID+ in the last 3 months. We haven't had a patient, who was ill from COVID, in a year or so. An interesting dev...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Infectious Disease · Astria Sunnyside Hospital

Due to my first-hand experience of taking Paxlovid as well as my immediate friends and family, I prefer to take it rather than just wait for natural immunity to work. COVID-19 has caused so many long-term side effects, so do not want those clots or fibrosis to happen. I was able to bounce back to my...

Register or Sign In to see full answer

What is your approach to the use of Paxlovid for patients with risk factors for severe Covid-19 infection but who have received SARS-CoV-2 vaccines in light of the EPIC-SR trial findings? | Mednet